tiprankstipranks

Ron Cohen Insider Profile

4 Followers
Ron Cohen, President & CEO, Director at Acorda Therapeutics, holds 149.76K shares in Acorda Therapeutics (Ticker: ACOR), holds 0.00 shares in Dyax Corp (Ticker: DYAX). Most recently, Ron Cohen Bought ― shares of Acorda Therapeutics on Mar 20, 2023 for an estimated value of 12.59K.
tipranks
Ron Cohen

Ron Cohen
Acorda Therapeutics (ACOR)
President & CEO, Director

Ranked #18,767 out of 97,825 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+23.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Ron Cohen's holdings

Insider Roles

Acorda Therapeutics
(ACOR)
President & CEO, Director
Roles that Ron Cohen holds in companies

Most Profitable Insider Trade

Stock:
Acorda Therapeutics
(ACOR)
Rating:Informative Buy
Date:Jun 20, 2017 - Jun 20, 2018
Return:+68.00%
The most profitable trade made by Ron Cohen

Ron Cohen's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Acorda Therapeutics
Mar 20, 2023
President & CEO, Director
Informative Buy
12.59K
$1.78M
DYAX
Dyax Corp
Jan 22, 2016
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Ron Cohen's performance on stock

Ron Cohen insider profile FAQ

What is the percentage of profitable transactions made by Ron Cohen?
The percentage of profitable transactions made by Ron Cohen is 75%.
    What is the average return per transaction made by Ron Cohen?
    The average return per transaction made by Ron Cohen is 23.00%.
      What stocks does Ron Cohen hold?
      Ron Cohen holds: ACOR, DYAX stocks.
        What was Ron Cohen’s latest transaction?
        Ron Cohen latest transaction was an Informative Buy of $12.59K.
          What was Ron Cohen's most profitable transaction?
          Ron Cohen’s most profitable transaction was an Informative Buy of ACOR stock on June 20, 2017. The return on the trade was 68.00%.
            What is Ron Cohen's role in Acorda Therapeutics?
            Ron Cohen's role in Acorda Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.